Generics in South Africa
Description
Generics in South Africa
Summary
Generics in South Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Generics in South Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.
- The South African generics market recorded revenues of $2.0 billion in 2024, representing a compound annual growth rate (CAGR) of 2.5% between 2019 and 2024.
- Market consumption volume increased with a CAGR of 2.6% between 2019 and 2024, reaching a total of 69.0% of total pharma volume in 2024.
- In 2024, the revenue of the South African generics market experienced an annual growth of 2.3%. The market’s growth is driven by the rising prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions, increasing the demand for affordable, long-term medications.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in South Africa
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in South Africa
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the South Africa generics market with five year forecasts by both value and volume
- What was the size of the South Africa generics market by value in 2024?
- What will be the size of the South Africa generics market in 2029?
- What factors are affecting the strength of competition in the South Africa generics market?
- How has the market performed over the last five years?
- Who are the top competitors in South Africa's generics market?
Table of Contents
41 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Market volume
- 1.4. Market volume forecast
- 1.5. Geography segmentation
- 1.6. Market rivalry
- 1.7. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 3.2. Market volume
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 5.2. Market volume forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strategies of the leading players?
- 7.3. What are the strengths of the leading players?
- 8 Company Profiles
- 8.1. Aspen Pharmacare Holdings Ltd
- 8.2. Adcock Ingram Holdings Ltd
- 8.3. Teva Pharmaceutical Industries Ltd
- 8.4. Cipla Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: South Africa generics market value: $ million, 2019-24
- Table 2: South Africa generics market volume: % of total pharma volume, 2019-24
- Table 3: South Africa generics market geography segmentation: $ million, 2024
- Table 4: South Africa generics market value forecast: $ million, 2024-29
- Table 5: South Africa generics market volume forecast: % of total pharma volume, 2024-29
- Table 6: Aspen Pharmacare Holdings Ltd: Key Facts
- Table 7: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
- Table 8: Aspen Pharmacare Holdings Ltd: Key Employees
- Table 9: Adcock Ingram Holdings Ltd: Key Facts
- Table 10: Adcock Ingram Holdings Ltd: Key Employees
- Table 11: Teva Pharmaceutical Industries Ltd: Key Facts
- Table 12: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
- Table 13: Teva Pharmaceutical Industries Ltd: Key Employees
- Table 14: Cipla Ltd: Key Facts
- Table 15: Cipla Ltd: Annual Financial Ratios
- Table 16: Cipla Ltd: Key Employees
- Table 17: South Africa Size of Population (Million), 2020-23
- Table 18: South Africa Real GDP (Constant 2010 Prices, $ Billion), 2020-24
- Table 19: South Africa GDP (Current Prices, $ Billion), 2020-24
- Table 20: South Africa Inflation, 2020-23
- Table 21: South Africa Consumer Price Index (Absolute), 2020-24
- Table 22: South Africa Exchange Rate, 2019-24
- List of Figures
- Figure 1: South Africa generics market value: $ million, 2019-24
- Figure 2: South Africa generics market volume: % of total pharma volume, 2019-24
- Figure 3: South Africa generics market geography segmentation: % share, by value, 2024
- Figure 4: South Africa generics market value forecast: $ million, 2024-29
- Figure 5: South Africa generics market volume forecast: % of total pharma volume, 2024-29
- Figure 6: Forces driving competition in the generics market in South Africa, 2024
- Figure 7: Drivers of buyer power in the generics market in South Africa, 2024
- Figure 8: Drivers of supplier power in the generics market in South Africa, 2024
- Figure 9: Factors influencing the likelihood of new entrants in the generics market in South Africa, 2024
- Figure 10: Factors influencing the threat of substitutes in the generics market in South Africa, 2024
- Figure 11: Drivers of degree of rivalry in the generics market in South Africa, 2024
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

